Obesity Drug Access and Clinical Advances

Medicare expands coverage, Medicaid cuts; retatrutide shows 22.6% weight loss; GLP-1s linked to 17.3% sick leave reduction; SAFE Drugs Act amended to protect compounded GLP-1s; Fajgenbaum reports 30-50% cancer progression reduction. Pfizer acquires Metsera for $10B to enter obesity market, Q2 surge driven by non-Covid products.